Medicine Gave Itself a Code for Diabetes Remission. A Year Later, the Payment System Still Can’t See It.
By HANA KAHLEOVA “Will this only get worse?” Patients with type 2 diabetes have asked…
Medicine Gave Itself a Code for Diabetes Remission. A Year Later, the Payment System Still Can’t See It.
By HANA KAHLEOVA “Will this only get worse?” Patients with type 2 diabetes have asked me some version of that question for my entire career. For most of it, the honest answer was “probably.” We treated diabetes as a one-way street: glucose climbs, medications pile up, complications follow. Good care slowed the slope. It didn’t…
FDA Official Believes GenAI-enabled Tools Will Need to Be Assessed Like a Physician
Rick Abramson, a radiologist by training and the director of FDA’s Digital Health Center of Excellence said, “We ended up putting out this idea that maybe these devices are starting to behave a little bit more like me as a physician than a heart valve or a defibrillator.” The post FDA Official Believes GenAI-enabled Tools…
Readily Secures $11M for Compliance Intelligence Platform
The Series A round was led by Define Ventures, with participation from Y Combinator and the California Health Care Foundation Innovation Fund. The post Readily Secures $11M for Compliance Intelligence Platform appeared first on MedCity News.
NAACOS Award Winners Share Keys to Success
Clinical leaders from Bryan Health Connect ACO, Ochsner Accountable Care Network, and TriValley Primary Care discuss lessons learned
GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer
The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular genetic signature. It’s a label expansion for Jemperli, which was initially approved as a treatment for endometrial cancer The post GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer appeared first on MedCity News.
A Radical Proposal to Preserve Cell and Gene Therapy Innovation
Cell and gene therapies are amazing medical breakthroughs but if we don’t find ways to pay for them, the development pipeline will fail. The post A Radical Proposal to Preserve Cell and Gene Therapy Innovation appeared first on MedCity News.
KFF Tracking Poll on Health Information and Trust: Fall 2026 Update on Vaccine Views
The latest KFF Tracking Poll on Health Information and Trust finds about half of parents mistakenly believe spacing out vaccines is healthier for children, while confidence in many long-standing childhood vaccines is high across partisans. These findings take on new relevance following President Trump’s recent executive order calling for changes in U.S. childhood vaccine recommendations,…
Report: Health System M&A Activity Remains Steady in Third Quarter
A new report on third quarter M&A activity in the healthcare sector found that this quarter’s hospital and health system transactions remained steady, with 2026 potentially set to be a top year for total annual transactions since pre-pandemic times. The post Report: Health System M&A Activity Remains Steady in Third Quarter appeared first on MedCity…
Democrats Demand Tougher Standards for Companies Running Medicaid Systems
A group of Democratic senators is demanding that the federal agency overseeing Medicaid — the health coverage program for people with low incomes or disabilities — institute tougher standards for government contractors running complex computer systems that millions of people rely on to get benefits. Three Democratic senators issued recommendations a year after launching an…
